Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

E-Z-Em buys into ITI Technologies:

This article was originally published in Clinica

Executive Summary

E-Z-Em has purchased 25% of Lawrence Livermore Laboratories' spin-off company, ITI Medical Technologies, in order to develop and commercialise interventional MRI devices. E-Z-Em already makes MR-compatible biopsy needles and breast lesion marking systems. E-Z-Em, which claims to be the world's largest maker of contrast agents for gastrointestinal radiology, has also signed an agreement with Eastman Kodak to become a preferred supplier in Kodak's Procedure Cost Management Alliance.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT085880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel